By ANDREW POLLACK
Flibanserin, which aims to restore lost libido in women, has been twice rejected by the F.D.A., which cited limited effectiveness as well as side effects. The drug will go before agency advisers again on Thursday.
Published: June 1, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1FW8TR6
from WordPress http://ift.tt/1KwXAyD
via Hadi Aboukhater
No comments:
Post a Comment